2Brandt MC, Mahfoud F, Bohm M, et al. Renal sympathetic denervation. A novel interventiona] treatment option for therapy-resistant arterial hypertension[J]. Herz, 2011, 36 8-11.
3Di Danie]e N, De Francesco M, Violo L, et al. Renal sympa-thetie nerve ablation for the treatment of difficult-to- control or refractory hypertension in a haemodialysis patient[J]. Nephrol Dial Transplant, 2012,2 1689-1690.
4Morishita , Hanawa S, Chinda J, et al. Effects of alis- kiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension[J]. Hypertens Res, 2011,34: 308-313.
5Bzoma B, Debska-Slizien A, Dudziak M, et al. Genetic predisposition to systemic complications of arterial hypertension in maintenance haemodialysis patients[J]. Pol Merkur Lekarsks, 2008,25: 209-216.
6Inrig JK, Van Buren P, Kim C, et al. Probing the Mechanisms of Intradialytic Hypertension: A Pilot Study Targeting Endothelial Cell Dysfunction[J]. Clin J Am Soc Nephrol, 2012, Jun 14, Epub ahead of print.
7Inrig JK, Van Buren P, Kim C, et al. Intradialytic hypertension and its association with endothelial cell dysfunction[J]. Clin J Am Soc Nephrol, 2011, 6:2016 2024.
8Jourde-Chiche N, Dou L, Sabatier F, et al. Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in bemodialysis patients [J]. J Thromb Haemost, 2009, 7: 1576-1584.
